Logo image of CY4.MI

CY4GATE SPA (CY4.MI) Stock Fundamental Analysis

BIT:CY4 - Euronext Milan - IT0005412504 - Common Stock - Currency: EUR

3.785  -0.03 (-0.79%)

Fundamental Rating

3

Overall CY4 gets a fundamental rating of 3 out of 10. We evaluated CY4 against 95 industry peers in the Software industry. CY4 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CY4 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CY4 had negative earnings in the past year.
CY4 had a positive operating cash flow in the past year.
CY4 had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CY4 reported negative operating cash flow in multiple years.
CY4.MI Yearly Net Income VS EBIT VS OCF VS FCFCY4.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.75%, CY4 is doing worse than 75.79% of the companies in the same industry.
Looking at the Return On Equity, with a value of -28.80%, CY4 is doing worse than 70.53% of the companies in the same industry.
Industry RankSector Rank
ROA -14.75%
ROE -28.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CY4.MI Yearly ROA, ROE, ROICCY4.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

CY4 has a worse Gross Margin (49.73%) than 68.42% of its industry peers.
CY4's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CY4 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5Y50.92%
CY4.MI Yearly Profit, Operating, Gross MarginsCY4.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

CY4 does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for CY4. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CY4.MI Yearly Shares OutstandingCY4.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
CY4.MI Yearly Total Debt VS Total AssetsCY4.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 0.83, we must say that CY4 is in the distress zone and has some risk of bankruptcy.
CY4's Altman-Z score of 0.83 is on the low side compared to the rest of the industry. CY4 is outperformed by 69.47% of its industry peers.
The Debt to FCF ratio of CY4 is 2.17, which is a good value as it means it would take CY4, 2.17 years of fcf income to pay off all of its debts.
CY4's Debt to FCF ratio of 2.17 is fine compared to the rest of the industry. CY4 outperforms 63.16% of its industry peers.
CY4 has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
CY4 has a Debt to Equity ratio (0.36) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.17
Altman-Z 0.83
ROIC/WACCN/A
WACC8.98%
CY4.MI Yearly LT Debt VS Equity VS FCFCY4.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.86 indicates that CY4 should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.86, CY4 is doing good in the industry, outperforming 74.74% of the companies in the same industry.
CY4 has a Quick Ratio of 1.84. This is a normal value and indicates that CY4 is financially healthy and should not expect problems in meeting its short term obligations.
CY4 has a better Quick ratio (1.84) than 74.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.84
CY4.MI Yearly Current Assets VS Current LiabilitesCY4.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

CY4 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -588.90%.
The Revenue has grown by 22.99% in the past year. This is a very strong growth!
The Revenue has been growing by 66.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-588.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.94%
Revenue 1Y (TTM)22.99%
Revenue growth 3Y74.28%
Revenue growth 5Y66.46%
Sales Q2Q%47.6%

3.2 Future

CY4 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.30% yearly.
The Revenue is expected to grow by 9.87% on average over the next years. This is quite good.
EPS Next Y17.38%
EPS Next 2Y26.92%
EPS Next 3Y28.75%
EPS Next 5Y29.3%
Revenue Next Year16.87%
Revenue Next 2Y12.33%
Revenue Next 3Y7.13%
Revenue Next 5Y9.87%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CY4.MI Yearly Revenue VS EstimatesCY4.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CY4.MI Yearly EPS VS EstimatesCY4.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CY4. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CY4. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CY4.MI Price Earnings VS Forward Price EarningsCY4.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than CY4, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.06
EV/EBITDA N/A
CY4.MI Per share dataCY4.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as CY4's earnings are expected to grow with 28.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.92%
EPS Next 3Y28.75%

More info and screens

0

5. Dividend

5.1 Amount

CY4 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CY4GATE SPA

BIT:CY4 (4/30/2025, 7:00:00 PM)

3.785

-0.03 (-0.79%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.64%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap89.21M
Analysts86.67
Price Target5.66 (49.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-3.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.6%
PT rev (3m)-18.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-701.2%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.01
P/FCF 4.06
P/OCF 3.31
P/B 0.92
P/tB 6.99
EV/EBITDA N/A
EPS(TTM)-1.14
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.93
FCFY24.66%
OCF(TTM)1.14
OCFY30.23%
SpS3.74
BVpS4.1
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.75%
ROE -28.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.73%
FCFM 24.95%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5Y50.92%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.17
Debt/EBITDA N/A
Cap/Depr 28.09%
Cap/Sales 5.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.84
Altman-Z 0.83
F-Score3
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)17.19%
Cap/Depr(5y)62.53%
Cap/Sales(3y)3.95%
Cap/Sales(5y)7.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-588.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.94%
EPS Next Y17.38%
EPS Next 2Y26.92%
EPS Next 3Y28.75%
EPS Next 5Y29.3%
Revenue 1Y (TTM)22.99%
Revenue growth 3Y74.28%
Revenue growth 5Y66.46%
Sales Q2Q%47.6%
Revenue Next Year16.87%
Revenue Next 2Y12.33%
Revenue Next 3Y7.13%
Revenue Next 5Y9.87%
EBIT growth 1Y-3687.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year510.99%
EBIT Next 3Y85.69%
EBIT Next 5Y72.14%
FCF growth 1Y1156.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2178.38%
OCF growth 3YN/A
OCF growth 5YN/A